Narrow Results

The following topics are under this section:

• Asia-Pacific — MIT's research enterprise in Singapore (SMART) launches new research group, boosting nation's cell therapy R&D
• Asia-Pacific — Potential cancer treatment strategies for humans from mechanisms behind low cancer occurrence in bats
• Asia-Pacific — Singapore scientists uncover mechanism behind development of viral infections
• Asia-Pacific — Exosomes found to aid in fighting Dengue infection
• Asia-Pacific — National platforms created to accelerate Singapore's drug development efforts
• Rest of the World — Cybersecurity company threat report details cyberattacks targeting the healthcare industry
• Rest of the World — Artificial intelligence – designed influenza vaccine begins clinical trials in the US
• Rest of the World — Clinical – stage biotechnology company presents Murlentamab phase II study results in colorectal cancer

The following topics are under this section:

• Collaborative launch of translational R&D hub to enhance clinical diagnostic development efforts
• Development of artificial intelligence (AI) tools and analytics platforms for improving cell therapy and immuno-oncology
• Entering the China market to provide regional support
• New funding help to support expansion of eye treatment facilities across Vietnam
• Alarm raised over increased targeted cyberattacks against pharmaceutical industry
• Joint fundraising acceleration programme to support development of tech companies and expand investor community
• Asia’s first FemTech innovations group to offer healthcare solutions unique to Asian women
• Population-Based Public Health initiative in Singapore leverages on digital health platforms
• Malaysian subsidiary of major biopharmaceutical company receives GMP Certification for compliance
• E-paper technology to support unmanned retail outlet in Hong Kong Science Park
• Novena Global Lifecare acquires three Taiwanese healthcare players